浙江东方：11月13日召开董事会会议

Core Viewpoint - Zhejiang Dongfang announced the establishment of the "Dongfang Zhe Pharmaceutical Zhongying Binjiang Medical Fund" through a subsidiary, indicating a strategic move to enhance its investment portfolio and engage in related transactions [1] Company Summary - The company's revenue composition for the year 2024 is as follows: futures business accounts for 82.69%, financing leasing for 5.48%, other businesses for 4.21%, insurance for 4.07%, and trust business for 3.31% [1] - As of the report, Zhejiang Dongfang has a market capitalization of 23.7 billion yuan [1]